Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
16.02
-1.03 (-6.04%)
Official Closing Price
Updated: 7:00 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
GLP-1 Treatments, Anticancer Research, and Emerging Therapeutic Technologies Are Driving the Next Chapter of Pharmaceutical Innovation
From
FN Media
Via
GlobeNewswire
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:LLY),(NYSE:HIMS),(TSXV:PAIN),(CSE:VLAB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
November 18, 2026
From
Hims & Hers
Via
Business Wire
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
November 11, 2026
Healthcare Innovation and Technology Adoption Are Reshaping How Millions of Patients Access Medical Services
From
FN Media
Via
GlobeNewswire
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
November 11, 2026
EQNX::TICKER_START (OTCQB:AIRDF),(CSE:AIDR),(NYSE:TDOC),(NYSE:AMWL),(NYSE:HIMS),(NYSE:DOCS) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Dr. Andrew Huberman Joins Hims & Hers Board of Directors
November 09, 2026
From
Hims & Hers
Via
Business Wire
Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results
November 09, 2026
From
Hims & Hers
Via
Business Wire
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
November 06, 2026
From
Hims & Hers
Via
Business Wire
Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across the $164 Billion Peptide Market
November 05, 2026
New HHS Direction Creates Potential Opportunities for Peptide Manufacturers, Biotech Companies, and Healthcare Innovators
From
FN Media
Via
GlobeNewswire
Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across The $164 Billion Peptide Market
November 05, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NASDAQ:MBX),(NASDAQ:KLRA),(NASDAQ:ALT),(NYSE:HIMS) EQNX::TICKER_END
Via
FinancialNewsMedia
Hims & Hers Benefits Adds Grüns, Medjet, Tonal, and Viome for Whole-Body Health and Support When You Need It Most
November 05, 2026
From
Hims & Hers
Via
Business Wire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Hims (NYSE: HIMS) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
November 02, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
November 02, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
HIMS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Hims & Hers Health, Inc. Investors to Contact the Firm Before November 2nd
October 31, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Hims & Hers Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
October 30, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Kaplan Fox Urges Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026
October 30, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
October 29, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
October 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
October 29, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments.
From
FN Media
Via
GlobeNewswire
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
HIMS Deadline in 5 Days: Hims & Hers Health, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP
October 28, 2026
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Kaplan Fox Advises Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Deadline on November 2, 2026
October 28, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
October 27, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS
October 27, 2026
From
Pomerantz LLP
Via
GlobeNewswire
HIMS URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd
October 27, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors That Time Is Running Out to Lead the Securities Class Action - Deadline November 2, 2026
October 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Who Suffered Losses to Seek a Leadership Role Before November 2, 2026
October 26, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
October 26, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
HIMS Deadline: Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights
October 25, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1